Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

China flag China · Delayed Price · Currency is CNY
13.88
+0.27 (1.98%)
Jul 30, 2026, 9:25 AM CST
Market Cap11.29B -11.7%
Revenue (ttm)4.04B -0.4%
Net Income759.89M +7.9%
EPS0.92 +10.8%
Shares Out 813.76M
PE Ratio15.09
Forward PEn/a
Dividend0.35 (2.57%)
Ex-Dividend DateJun 11, 2026
Volume84,200
Open13.77
Previous Close13.61
Day's Range13.54 - 13.94
52-Week Range11.45 - 22.62
Beta-0.11
Analystsn/a
Price Targetn/a
Earnings DateAug 27, 2026

About SHE:002020

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactat... [Read more]

Sector Healthcare
Founded 1990
Employees 3,732
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002020
Full Company Profile

Financial Performance

In 2025, SHE:002020's revenue was 4.07 billion, a decrease of -2.14% compared to the previous year's 4.16 billion. Earnings were 757.98 million, an increase of 6.46%.

Financial Statements